Simon, Christopher 4
4 · HAEMONETICS CORP · Filed Sep 3, 2024
Insider Transaction Report
Form 4
Simon, Christopher
DirectorPresident & CEO
Transactions
- Other
Common Stock
2024-08-29$75.56/sh−39,704$3,000,034→ 322,838 total
Footnotes (2)
- [F1]On August 29, 2024, in an asset substitution transaction, Mr. Simon transferred 39,704 shares of the Issuer's common stock to the Simon Family Irrevocable Trust for the benefit of the reporting person's children, in exchange for cash in the amount of $3,000,034, with the number of shares determined by averaging the high and low sales prices of the Issuer's common stock as reported by the New York Stock Exchange on August 29, 2024. The substitution was made in accordance with the terms of the trust, which has an independent trustee.
- [F2]This number includes unvested restricted stock units previously reported.